Accelerating Asia’s digital GMP transformation with industry 4.0 technologies

Posted on March 31, 2022 by Lorenzo Sarasa

The post-pandemic boom has led many pharma leaders in the APAC market to look at adopting industry 4.0 technologies for their digital transformation.

According to a report by IDC, the three most important trends that came to light because of the pandemic included:

Global supply chain vulnerability needing to be addressed strategically
Incentives needing to increase manufacturing footprints to meet global/regional demand
Manufacturing of more pharmaceuticals moving locally to better serve home markets

Kenneth Tao (Client Service Executive & Associate Director at Cognizant) explores how all three trends can be addressed by advanced digital and analytical infrastructures. Find out more on how Tao envisages pharma’s journey to 4.0 transition here (pages 22-24).

Read the full article on pages 22-24:

Comments are closed.